198 related articles for article (PubMed ID: 22095224)
1. Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.
Scaggiante B; Dapas B; Bonin S; Grassi M; Zennaro C; Farra R; Cristiano L; Siracusano S; Zanconati F; Giansante C; Grassi G
Br J Cancer; 2012 Jan; 106(1):166-73. PubMed ID: 22095224
[TBL] [Abstract][Full Text] [Related]
2. High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy.
Bosutti A; Dapas B; Grassi G; Bussani R; Zanconati F; Giudici F; Bottin C; Pavan N; Trombetta C; Scaggiante B
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456960
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients.
Bosutti A; Scaggiante B; Grassi G; Guarnieri G; Biolo G
Metabolism; 2007 Dec; 56(12):1629-34. PubMed ID: 17998013
[TBL] [Abstract][Full Text] [Related]
4. [Role of Eukaryotic Translation Elongation Factor 1 Family Members in the Tumorigenesis and Progression of Lung Adenocarcinoma].
Wu Y; Liu JF; Liang WF; Yang YH; Hu G; Yang JT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):867-885. PubMed ID: 38173097
[TBL] [Abstract][Full Text] [Related]
5. A rapid and specific method to simultaneously quantify eukaryotic elongation factor 1A1 and A2 protein levels in cancer cells.
Bosutti A; Kalaja O; Zanconati F; Dapas B; Grassi G; Passamonti S; Scaggiante B
J Pharm Biomed Anal; 2019 Nov; 176():112814. PubMed ID: 31450069
[TBL] [Abstract][Full Text] [Related]
6. Porcine EEF1A1 and EEF1A2 genes: genomic structure, polymorphism, mapping and expression.
Svobodová K; Horák P; Stratil A; Bartenschlager H; Van Poucke M; Chalupová P; Dvořáková V; Knorr C; Stupka R; Čítek J; Šprysl M; Palánová A; Peelman LJ; Geldermann H; Knoll A
Mol Biol Rep; 2015 Aug; 42(8):1257-64. PubMed ID: 25749814
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Expression and Subcellular Distribution of
Wefers Z; Alecki C; Huang R; Jacob-Tomas S; Vera M
Cells; 2022 Jun; 11(12):. PubMed ID: 35741005
[TBL] [Abstract][Full Text] [Related]
8. Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells.
Dapas B; Pozzato G; Zorzet S; Capolla S; Macor P; Scaggiante B; Coan M; Guerra C; Gnan C; Gattei V; Zanconati F; Grassi G
Int J Pharm; 2020 Jan; 574():118895. PubMed ID: 31862491
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.
Rehman I; Evans CA; Glen A; Cross SS; Eaton CL; Down J; Pesce G; Phillips JT; Yen OS; Thalmann GN; Wright PC; Hamdy FC
PLoS One; 2012; 7(2):e30885. PubMed ID: 22355332
[TBL] [Abstract][Full Text] [Related]
10. Prostate-tumor-inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection.
Scaggiante B; Bonin S; Cristiano L; Siracusano S; Stanta G; Dapas B; Giansante C; Fiotti N; Grassi G
Cancer Invest; 2008 Oct; 26(8):800-8. PubMed ID: 18853312
[TBL] [Abstract][Full Text] [Related]
11. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
13. Endogenous epitope tagging of eEF1A2 in mice reveals early embryonic expression of eEF1A2 and subcellular compartmentalisation of neuronal eEF1A1 and eEF1A2.
Davies FCJ; Marshall GF; Pegram E; Gadd D; Abbott CM
Mol Cell Neurosci; 2023 Sep; 126():103879. PubMed ID: 37429391
[TBL] [Abstract][Full Text] [Related]
14. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours.
Tomlinson VA; Newbery HJ; Wray NR; Jackson J; Larionov A; Miller WR; Dixon JM; Abbott CM
BMC Cancer; 2005 Sep; 5():113. PubMed ID: 16156888
[TBL] [Abstract][Full Text] [Related]
15. A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules.
Panasyuk G; Nemazanyy I; Filonenko V; Negrutskii B; El'skaya AV
Int J Biochem Cell Biol; 2008; 40(1):63-71. PubMed ID: 17936057
[TBL] [Abstract][Full Text] [Related]
16. Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo.
Du YF; Shi Y; Xing YF; Zeng FQ
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1255-64. PubMed ID: 18431597
[TBL] [Abstract][Full Text] [Related]
17. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
18. [Eukaryotic translation elongation factor 1A1 positively regulates NOB1 expression to promote invasion and metastasis of hepatocellular carcinoma cells
Zhang W; Xiang M; Zheng C; Chen L; Ge J; Yan C; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1195-1202. PubMed ID: 30377124
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
20. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
